<DOC>
	<DOCNO>NCT02217527</DOCNO>
	<brief_summary>The study ass novel active drug vs. placebo ability reduce smoking aid cessation one-week `` practice '' quit period condition smoker high interest quitting ( i.e . crossover design ) . Medication effect reduce craving , withdrawal , cognitive impairment help assess mechanism support quit smoke attempt .</brief_summary>
	<brief_title>Test Novel Drug Smoking Cessation</brief_title>
	<detailed_description />
	<criteria>Healthy male female dependent smoker want quit soon Use nonsmoked nicotine product Already enrolled cessation program . Recent alcohol substance dependence ( â‰¤ 3 month ) Women pregnant , planning pregnancy , lactate ; female participant shall undergo pregnancy test screening exclude positive . Serious unstable medical disorder within past 3 month Epilepsy Current diagnosis ( within last 6months ) abnormal cardiac rhythm ; unstable cardiovascular disease e.g . stroke , myocardial infarction last 6 month Evidence impair liver function test ( LFT ) Evidence kidney failure Any subject history hematological cancer example : leukemia , lymphoma etc . Any clinically significant hematological laboratory abnormality .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>crossover</keyword>
</DOC>